From: Psychotropic medication use among adolescents participating in three randomized trials of DBT
Characteristic | US sample (N = 173) | Oslo sample (N = 77) | Barcelona sample (N = 35) | |||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Sociodemographic characteristics | ||||||
Female sex | 163 | 94.8 | 68 | 88.3 | 31 | 88.6 |
Age, mean (SD) years | 14.9 | 1.5 | 15.6 | 1.5 | 15.0 | 1.4 |
Parents currently co-habiting | 82 | 54.7 | 34 | 44.2 | 14 | 40.0 |
Race/ethnicity | ||||||
Caucasian/White | 97 | 56.4 | 66 | 85.7 | 26 | 74.3 |
Latina | 48 | 27.5 | 3 | 3.9 | 5 | 14.3 |
Black/African American | 12 | 7.0 | 0 | 0 | 1 | 2.8 |
Asian | 10 | 5.9 | 5 | 6.5 | 2 | 5.7 |
Other | 5 | 2.9 | 3 | 3.9 | 1 | 2.8 |
Family annual income | ||||||
< 15 000 $ or € Equivalent | 15 | 11.0 | - | - | 6 | 17.2 |
15 000–29 999 | 9 | 6.6 | - | - | 4 | 11.4 |
30 000–49 999 | 25 | 17.4 | - | - | 9 | 25.7 |
≥ 50 000 | 95 | 65.3 | - | - | 16 | 45.7 |
Clinical characteristics Current psychiatric diagnosis | ||||||
Any depressive disorder | 145 | 83.8 | 46 | 59.7 | 29 | 82.9 |
Major depressive disorder | 142 | 82.1 | 17 | 22.1 | 29 | 82.9 |
Bipolar disorders | - | - | 0 | 0 | 5 | 14.2 |
Any anxiety disorder | 93 | 54.1 | 33 | 42.9 | 19 | 54.3 |
Posttraumatic stress disorder | 78 | 45.1 | 13 | 16.9 | 8 | 22.9 |
Any substance use disorder | - | - | 2 | 2.6 | 15 | 42.9 |
Eating disorder | 1 | 0.7 | 6 | 7.8 | 18 | 51.4 |
Borderline Personality disorder | 92c | 53.2 | 15c | 20.5 | - | - |
ADHD | - | - | 4 | 5.2 | 11 | 31.4 |
Self-harm and related variables | ||||||
Suicidal ideation mean (SD)a | 47.6 | 17.4 | 36.9 | 23.7 | 45.2 | 17.1 |
Any lifetime NSSI (l%) | 163 | 94.2 | 77 | 100 | 35 | 100 |
Lifetime number of NSSI (SD) | 26.3 | 47.2 | 34.0 | 88.0 | - | - |
Any Lifetime Suicide attempt (%)b | 173 | 100 | 26 | 38 | 26 | 74.3 |
Number of SA (lifetime) mean (SD) | - | - | 1.7 | 4.2 | 1.9 | 1.8 |
Level of functioning (C-GAS) mean (SD) | 45.2 | 7.4 | 56.1 | 8.3 | 53.1 | 6.4 |